Immune cells in the bone marrow microenvironment of AML patients are key in distinguishing a response to immunotherapy.

Jewel Plummer Cobb was a cancer researcher who investigated how hormones, ultraviolet light and chemotherapeutic drugs can ...

Researchers developed a technique to gain a deeper understanding of ribosome function and their cooperative behaviors.

Cellular metabolism is a powerful indicator of cell activation, differentiation, growth, cell death and disease progression. Therefore, metabolite monitoring offers a way for ...

Molecular biology is concerned with understanding processes in living organisms at a molecular level, as well as the chemical and physical structure of macromolecules. Molecular biologists focus on ...

Tony Oosterveen (left) is a Principal Scientist at bit.bio (Cambridge, UK), a company pioneering the generation of physiologically relevant human cell types from induced pluripotent stem cells (iPSCs) ...

A great deal has changed since April 2003 when the human genome was first sequenced. Now, Enhanced Genomics (Cambridge, UK) has developed a 3D multi-omic profiling technology, GenLink, that combines ...

NIH reviews, travel and communications have been frozen until 2 February at least. How has the scientific community responded? On day three of Trump’s presidency, the administration imposed a wide ...

A bioactive compound produced by an extremophilic bacterium has potential industrial applications. An international collaboration of researchers has isolated a bioactive compound in extremophilic ...

Zika virus hijacks a key protein implicated in brain development for its own replication. Researchers led by Associate Professor Priya Shah at the University of California, Davis (CA, USA), have ...

A recent study from researchers at Tulane University (LA, USA), led by Demetrius Maraganore, has utilized rat models to explore the potential role of the gut microbiome in the relationship between the ...

In this interview, Tong Huo discusses the current landscape of CAR-T therapies and the future of CAR-T, including next-generation approaches, gene-editing innovations and applications beyond oncology.